ProPhase Labs, Inc.
PRPH· OTC
Released Jun 30, 2026, after the close
10-Q filed Jun 30, 2026, 91 days after period end · 0001493152-26-031301
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $1.17M | $1.43M | $2.36M | $19.30M |
| Net Income | -$5.18M | $3.97M | -$6.27M | $550.00K |
| EPS Diluted | -$0.42 |
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR
| $1.13 |
| -$0.36 |
| $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.